Company Overview

Development Stage

About the Company

Jiangxi Yaoshizai Enterprise Management Co., Ltd. was established in April 2019. With "integrity, innovation, gratitude, altruism, and striving" as its core values, the company has received joint investment from a company planning to go public and Jiangxi Boliminkang Pharmaceutical Co., Ltd. In 2014, the pharmaceutical retail industry underwent tremendous changes, with the full implementation of the new version of GSP, and chain giants successively entering the capital market. Small and medium-sized chains and independent pharmacies were weak and isolated, lacking procurement advantages, operational features, and the ability to control their future. In March 2019, "4+7 volume-based procurement" was successively launched across the country, and generic drugs gradually approached the brink of zero profit. The costs of the pharmaceutical retail market continued to increase, and the profit margins of pharmacies and clinics gradually shrank. Nowadays, the state strictly controls the use of antibiotics, prohibits outpatient infusion, essential drugs have zero profit, controlled-sale products are expensive, there are many medical institutions and great competitive pressure, and clinic business models are monotonous... Yaoshizai people deeply empathize with this and are determined to strive to change the business model and lifestyle of pharmaceutical terminals. Yaoshizai focuses on the operation and services of pharmaceuticals, using new Internet models to change the traditional pharmaceutical business status quo, achieving "benefits for terminals, benefits for the people." Yaoshizai Enterprise Management Co., Ltd. was born against this background. Starting from products, relying on the Internet, pooling procurement, cutting out all intermediate links, and delivering directly to terminals, costs are saved by at least 50%. With controlled product sales, sufficient space is given to pharmacies and clinics, saving more than 100,000 yuan per year on product procurement. Using high-quality and low-cost drugs as a link, the company gradually integrates Baike Mingyi, licensed pharmacist courses, and carries out a series of services such as online classrooms, crowdfunding flash sales, and joint equipment procurement, uniting 100,000 terminals across the country into one group, aspiring to "become the best operator of new special drugs." Yaoshizai always adheres to the business philosophy of "real quality, real price, real service," and is determined to use our professionalism and hard work to become the best operator of new special drugs in Jiangxi and even the whole country.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (1 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 113%
  • 2024: Up 300%
  • 2023: Up 167%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at Jiangxi Yaoshizai Enterprise Management Co., Ltd. growing? 2026: 34 openings (down 50%), 2025: 68 openings (up 113%), 2024: 32 openings (up 300%), 2023: 8 openings (up 167%), 2022: 3 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (69 records)

Manage
salary range: 6K - 50K, 89.9% of roles pay ¥15-50K
Note: salary statistics are based on 69 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Jiangxi Yaoshizai Enterprise Management Co., Ltd.?89.9% of positions earn 15-50K, Nanchang salary ranking top 5,销售类 average salary ¥33.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Jiangxi Yaoshizai Enterprise Management Co., Ltd.? We provide: 销售,区域合伙人. Click to view detailed salary analysis by job.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    92.8% of total 92.8%
  • 医疗卫生/美容保健类
    10.1% of total 10.1%
  • 经营管理类
    10.1% of total 10.1%

Education

  • 不限
    52.2% of total 52.2%
  • 高中
    34.8% of total 34.8%
  • 大专
    13% of total 13%

Experience

  • 不限
    84.1% of total 84.1%
  • 1-3年
    15.9% of total 15.9%
View Detailed Analysis

What does Jiangxi Yaoshizai Enterprise Management Co., Ltd. require? Who is Jiangxi Yaoshizai Enterprise Management Co., Ltd. hiring? recruitment: 销售类占比最多占92.8%,其次是医疗卫生/美容保健类占10.1%. What education can get in at ? 不限占比最多占52.2%,其次是高中占34.8%. Work experience required at ? 不限占比最多占84.1%,其次是1-3年占15.9%. Where are the job locations at ? 淮南占比最多占5.8%,其次是淮北占5.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 500万(元)
Legal Representative: 胡恒标
Date Established:
Credit Code: 91360104MA38J77C5B
Registered Address: 江西省南昌市青山湖区民营科技园民安路99号研发中心2的1-4楼

People who follow this company also follow

Competitors (Similar Companies)

“The core platform of Sinopharm's Traditional Chinese Medicine industry”
能源 电力 工业 电力供应
照明 车灯 汽车照明 灯具
接头 加油车 洒水车 球阀
制药/药业 医药 体外诊断试剂 生物制品
软件 计算机服务 智慧农业 物流/运输信息化
医药电商 药品零售 药店连锁 零售连锁
智能座舱 车灯 汽车零部件/配件 工厂
芯片 芯片封装 电子厂/电子 微电子
医药工业
AMOLED 电源管理 电源 储能电池
产业研究 研究院/研究所 传统文化 科学研究
医院
海外 文化 品牌管理 内容制作
医学研究 药物研发 健康管理 医疗器械

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates